VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 740 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $18,831,345 | +6.1% | 555,006 | -1.1% | 6.34% | +7.2% |
| Q1 2024 | $17,747,447 | +6.1% | 561,272 | +4.1% | 5.92% | +4.6% |
| Q4 2023 | $16,722,997 | +42.3% | 539,277 | +23.5% | 5.66% | +33.7% |
| Q3 2023 | $11,751,864 | +11.3% | 436,709 | +24.5% | 4.23% | +18.6% |
| Q2 2023 | $10,559,997 | +2.1% | 350,714 | +9.7% | 3.57% | +5.2% |
| Q1 2023 | $10,344,020 | +46.9% | 319,753 | +30.2% | 3.39% | +52.5% |
| Q4 2022 | $7,040,432 | +126.2% | 245,654 | +90.4% | 2.22% | +108.5% |
| Q3 2022 | $3,112,000 | +12.5% | 129,026 | +27.7% | 1.07% | +28.4% |
| Q2 2022 | $2,766,000 | +14.7% | 101,009 | +60.6% | 0.83% | +29.5% |
| Q1 2022 | $2,412,000 | +31.8% | 62,903 | +10.1% | 0.64% | +33.0% |
| Q4 2021 | $1,830,000 | +61.2% | 57,145 | +48.4% | 0.48% | +53.5% |
| Q3 2021 | $1,135,000 | +38.9% | 38,513 | +60.2% | 0.31% | +43.4% |
| Q2 2021 | $817,000 | +50.5% | 24,038 | +43.9% | 0.22% | +47.0% |
| Q1 2021 | $543,000 | – | 16,700 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |